WARRANT NO. ________ THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY OR ACQUIRABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF...Spectrum Pharmaceuticals Inc • May 16th, 2003 • Pharmaceutical preparations • New York
WARRANTNeotherapeutics Inc • June 7th, 2002 • Pharmaceutical preparations
EXHIBIT 4.4 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of September 26, 2003, among Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and each of the purchasers...Registration Rights Agreement • September 30th, 2003 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
NEOTHERAPEUTICS, INC. 5% SUBORDINATED CONVERTIBLE DEBENTURE DUE [ ](1)Neotherapeutics Inc • November 13th, 2000 • Services-commercial physical & biological research
WARRANT NO. ______ THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY OR ACQUIRABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF AN...Spectrum Pharmaceuticals Inc • September 30th, 2003 • Pharmaceutical preparations • New York
AMONGStock Purchase Agreement • August 27th, 2001 • Neotherapeutics Inc • Pharmaceutical preparations • New York
1 EXHIBIT 4.3 NEOGENE TECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT DECEMBER 18, 2000 NEOGENE TECHNOLOGIES, INC. REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made as of December 18, 2000, between NeoGene...Registration Rights Agreement • December 28th, 2000 • Neotherapeutics Inc • Services-commercial physical & biological research • New York
May 17, 2001Letter Agreement • May 21st, 2001 • Neotherapeutics Inc • Pharmaceutical preparations
EXHIBIT 10.1 LIMITED LIABILITY COMPANY AGREEMENTLimited Liability Company Agreement • May 14th, 2003 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
betweenSettlement Agreement • November 13th, 2002 • Neotherapeutics Inc • Pharmaceutical preparations
EXHIBIT 4.1 THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER...Spectrum Pharmaceuticals Inc • November 15th, 2004 • Pharmaceutical preparations • New York
WARRANTSpectrum Pharmaceuticals Inc • May 17th, 2004 • Pharmaceutical preparations • California
INDENTURESpectrum Pharmaceuticals Inc • December 23rd, 2004 • Pharmaceutical preparations • New York
AMENDMENT NO. 1 OF THE PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENTSpectrum Pharmaceuticals Inc • May 16th, 2003 • Pharmaceutical preparations • New York
Exhibit 4.1 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of August 13, 2003, among Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and each of the purchasers...Registration Rights Agreement • August 15th, 2003 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 4.4 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of May 7, 2003, among Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and each of the purchasers...Registration Rights Agreement • May 16th, 2003 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 4.4 NEOTHERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this "Agreement") is made and entered into as of September 21, 2000, among NeoTherapeutics, Inc., a Delaware corporation (the "Company"), and each of...Registration Rights Agreement • November 13th, 2000 • Neotherapeutics Inc • Services-commercial physical & biological research • New York
ARTICLE II REPRESENTATIONS AND WARRANTIESSecurities Purchase Agreement • November 13th, 2000 • Neotherapeutics Inc • Services-commercial physical & biological research • New York
CREDIT AGREEMENT Dated as of September 5, 2012 among SPECTRUM PHARMACEUTICALS, INC., as the Borrower, THE SUBSIDIARIES OF THE BORROWER PARTY HERETO, as the Guarantors, BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer,...Credit Agreement • September 11th, 2012 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of September 5, 2012, among SPECTRUM PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein), and BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer.
EXHIBIT 4.46 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN...Neotherapeutics Inc • April 2nd, 2002 • Pharmaceutical preparations • California
21,666,667 Shares of Common Stock Spectrum Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 3rd, 2020 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.20 April 17, 2001 VIA TELECOPY (949) 788-6706 NeoTherapeutics, Inc. 157 Technology Drive Irvine, CA 92618 Attention: Chief Financial Officer Gentlemen: This letter evidences a binding agreement among NeoTherapeutics, Inc. (the "Company"),...Neotherapeutics Inc • April 25th, 2001 • Pharmaceutical preparations • New York
iii) If, on or prior to the Expiration Date (as defined in the Class B Warrant), the Company has failed to deliver one or more Call Notices (as defined in the Class B Warrant) pursuant to Section 3(a) of the Class B Warrant for a minimum of 500,000...Neotherapeutics Inc • April 21st, 2000 • Services-commercial physical & biological research • New York
ANDSupply Agreement • May 14th, 2003 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 4.1 NEOTHERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 25th, 2000 • Neotherapeutics Inc • Services-commercial physical & biological research • California
EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the "Agreement") is made as of November 21, 2002, by and between __________________ ("Purchaser"), and NeoTherapeutics, Inc. ("Company"), whereby the parties agree as...Securities Purchase Agreement • November 26th, 2002 • Neotherapeutics Inc • Pharmaceutical preparations • California
EXHIBIT 4.1 ADVISORY AGREEMENT AMENDMENT October 19, 2001 CANTOR FITZGERALD & CO. 299 Park Avenue, 29th Floor New York, NY 10171 Dear Sirs/Ladies: Pursuant to the terms of that certain Letter Agreement dated April 11, 2001, by and between Cantor...Neotherapeutics Inc • October 24th, 2001 • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 28th, 2009 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 27, 2009, between Spectrum Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
2- 3 (b) Except as otherwise set forth in this Warrant, this Warrant shall vest and become exercisable on a Vesting Date with respect to the number of Warrant Shares calculated in accordance with the following formula:Neotherapeutics Inc • November 13th, 2000 • Services-commercial physical & biological research • New York
EXHIBIT 1.1 5,134,100 SHARES SPECTRUM PHARMACEUTICALS, INC. SHARES OF COMMON STOCK (PAR VALUE $0.001 PER SHARE) PLACEMENT AGENT AGREEMENTSubscription Agreement • May 4th, 2007 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
WARRANTSpectrum Pharmaceuticals Inc • November 4th, 2005 • Pharmaceutical preparations • California
AMENDMENT NO. 1 TO MASTER LEASE AGREEMENT DATED SEPTEMBER 22, 2000 (THE "LEASE") BY AND BETWEEN NEOTHERAPEUTICS, INC. ("LESSEE") AND COMDISCO LABORATORY AND SCIENTIFIC GROUP, A DIVISION OF COMDISCO, INC. ("LESSOR")Master Lease Agreement • April 17th, 2001 • Neotherapeutics Inc • Pharmaceutical preparations
BY AND AMONGLicense Agreement • February 3rd, 2005 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
FIRST AMENDMENT TO LICENCE AGREEMENT DATED AUGUST 28, 2001 BETWEEN JOHNSON MATTHEY PLC AND NEOTHERAPEUTICS, INC.License Agreement • November 13th, 2002 • Neotherapeutics Inc • Pharmaceutical preparations
CONFIDENTIAL LICENSE AND COLLABORATION AGREEMENT FOR D-63153Spectrum Pharmaceuticals Inc • January 21st, 2005 • Pharmaceutical preparations
